Compumedics

Compumedics EBIT Margin

The EBIT Margin (Operating Margin) of Compumedics (CMP.AX) as of Oct 17, 2026 is 2.97 %. In the previous year, EBIT Margin (Operating Margin) was 1.40 % — a change of 112.01% (higher).

EBIT Margin

2.97 %

YoY

112.01%

Last updated:

EBIT Margin (Operating Margin) of Compumedics is 2026 2.97 % . EBIT Margin (Operating Margin) of Compumedics was 2025 1.40 % . It decreases by 112.01% higher compared to the previous year.

Compumedics's operating (EBIT) margin stands at 3.0%, up from 1.4% several years earlier.

The Compumedics EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2019
12.07 AUD
Jan 1, 2020
-2.16 AUD
Jan 1, 2021
3.09 AUD
Jan 1, 2022
1.42 AUD
Jan 1, 2023
-14.31 AUD
Jan 1, 2024
2.45 AUD
Jan 1, 2025
1.40 AUD
Jan 1, 2026
2.97 AUD
The Compumedics EBIT Margin history
YEAREBIT MarginYoY
2.97 %+112.01%
1.40 %-42.94%
2.45 %-117.14%
-14.31 %-1,103.99%
1.42 %-53.95%
3.09 %-243.55%
-2.16 %-117.86%
12.07 %+45.49%
8.29 %+101.33%
4.12 %-51.83%
8.55 %+6.65%
8.02 %+47.25%
5.45 %-17,133.97%
-0.03 %-69.99%
-0.11 %+154.07%
-0.04 %-456.10%
0.01 %-84.40%
0.08 %+533.10%
0.01 %-70.65%
0.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Compumedics Stock analysis

What does Compumedics do? Compumedics Ltd., headquartered in Melbourne, Australia, operates in the Health Care sector, specializing in the research, development, manufacture, and distribution of medical equipment. The company employs 135 full-time staff and serves global markets across the Americas, Australia, Asia Pacific, and Europe and the Middle East. Its product portfolio includes sleep diagnostic systems, clinical EEG systems, brain monitoring solutions, ultrasonic blood-flow systems, and technical support services. Key offerings encompass Somfit/Somfit Pro, Grael 4K PSG:EEG, and Compumedics Neuroscan for neurology applications and brain research technologies. Compumedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compumedics stock

EBIT Margin (Operating Margin) of Compumedics is 2.97 % in 2026.

EBIT Margin (Operating Margin) of Compumedics changed from 1.40 % to 2.97 %, representing a 112.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Compumedics since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Compumedics with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Compumedics

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Compumedics